Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ : revenue, balance sheet and financial ratios

SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ is a French company founded 8 years ago, specialized in the sector Activités des sièges sociaux. Based in HARLY (02100), this company of category PME shows in 2024 a net income positive of 185 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ (SIREN 830866661)
Indicator 2024 2023 2022 2021 2020 2019 2018
Revenue N/C N/C N/C N/C N/C N/C N/C
Net income 185 374 € 184 506 € 185 719 € 173 412 € 173 432 € 186 391 € 160 102 €
EBITDA -2 298 € -2 055 € -1 418 € -2 119 € -1 472 € -2 417 € -22 817 €
Net margin N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ generates positive net income of 185 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 160 k€ -> 185 k€.

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-2 298 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-2 298 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

185 374 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 70%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 5.6 years of cash flow to repay all financial debt. This ratio remains within usual banking standards.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

70.328%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

58.68%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

5.573

Solvency indicators evolution
SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ

Sector positioning

Debt ratio
70.33 2024
2022
2023
2024
Q1: 0.06
Med: 14.61
Q3: 89.57
Average -6 pts over 3 years

In 2024, the debt ratio of SPFPLARL DE PHARMACIENS D... (70.33) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
58.68% 2024
2022
2023
2024
Q1: 11.57%
Med: 51.97%
Q3: 85.24%
Good +11 pts over 3 years

In 2024, the financial autonomy of SPFPLARL DE PHARMACIENS D... (58.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
5.57 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.2 years
Q3: 3.73 years
Average

In 2024, the repayment capacity of SPFPLARL DE PHARMACIENS D... (5.57) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 19953.41. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

19953.411

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-869.278

Liquidity indicators evolution
SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ

Sector positioning

Liquidity ratio
19953.41 2024
2022
2023
2024
Q1: 116.63
Med: 458.65
Q3: 2184.57
Excellent

In 2024, the liquidity ratio of SPFPLARL DE PHARMACIENS D... (19953.41) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
-869.28x 2024
2022
2023
2024
Q1: -45.56x
Med: 0.0x
Q3: 2.85x
Average

In 2024, the interest coverage of SPFPLARL DE PHARMACIENS D... (-869.3x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 168 days. Excellent situation: suppliers finance 168 days of the operating cycle (retail model).

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

168 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ

Positioning of SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ in its sector

Comparison with sector Activités des sièges sociaux

Valuation estimate

Based on 103 transactions of similar company sales in 2024, the value of SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ is estimated at 1 762 521 € (range 605 184€ - 4 745 916€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
103 transactions
605k€ 1762k€ 4745k€
1 762 521 € Range: 605 184€ - 4 745 916€
NAF 5 année 2024

Valuation method used

Net Income Multiple
185 374 € × 9.5x = 1 762 521 €
Range: 605 185€ - 4 745 917€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 103 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités des sièges sociaux)

Compare SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ with other companies in the same sector:

Voir toutes les statistiques du secteur Activités des sièges sociaux

Frequently asked questions about SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ

What is the revenue of SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ ?

The revenue of SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ is not publicly disclosed (confidential accounts filed with INPI).

Is SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ profitable?

Yes, SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ generated a net profit of 185 k€ in 2024.

Where is the headquarters of SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ ?

The headquarters of SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ is located in HARLY (02100), in the department Aisne.

Where to find the tax return of SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ ?

The tax return of SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ operate?

SPFPLARL DE PHARMACIENS D'OFFICINE SABINE LANEZ operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.